CHARACTERIZATION OF MUSCARINIC RECEPTOR SUBTYPES IN PIG AIRWAYS - RADIOLIGAND BINDING AND NORTHERN BLOTTING STUDIES

被引:31
作者
HADDAD, EB
MAK, JCW
HISLOP, A
HAWORTH, SG
BARNES, PJ
机构
[1] NATL HEART & LUNG INST,DEPT THORAC MED,LONDON SW3 6LY,ENGLAND
[2] INST CHILD HLTH,DIV PHYSIOL & PHARMACOL,LONDON SW3 6LY,ENGLAND
来源
AMERICAN JOURNAL OF PHYSIOLOGY | 1994年 / 266卷 / 06期
关键词
LUNG; TRACHEA; MUSCARINIC ANTAGONISTS; MESSENGER RIBONUCLEIC ACID;
D O I
10.1152/ajplung.1994.266.6.L642
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
This study was under-taken to characterize the muscarinic receptor subtypes present in adult pig peripheral lung and airway smooth muscle. The binding of the nonselective muscarinic antagonist [N-methyl-H-3]scopolamine ([H-3]NMS) to pig airways showed a single class of binding sites with a maximum density of 172 and 450 fmol/mg protein in peripheral lung and airway smooth muscle, respectively. Unlike [H-3]NMS, the M(1)-selective antagonist, [H-3]telenzepine, recognized two populations of binding sites in peripheral lung. Approximately 14% of total [H-3]telenzepine binding sites displayed high affinity [dissociation constant (K-d) = 0.95 nM], whereas the remaining sites showed low affinity (K-d = 14.2 nM). The high- and the low-affinity [H-3]telenzepine binding sites displayed the pharmacological profile of M(1) and M(2) receptors, respectively. Heterogeneity of pig airways muscarinic receptor was also revealed by competitive binding experiments against [H-3]NMS with the M(2)-selective antagonist methoctramine. This compound recognized 70 and 90% of total receptors with high affinity in airway smooth muscle (K-i = 4.44 nM) and peripheral lung (K-i = 9.82 nM), respectively. This result suggests that the dominant muscarinic receptor in pig airways is of the M(2) subtype. Northern blot analysis demonstrated the presence of m(1) and m(2) mRNAs transcripts in peripheral lung and m(2) and m(3) mRNAs in airway smooth muscle with no evidence for m(4) mRNA.
引用
收藏
页码:L642 / L648
页数:7
相关论文
共 38 条
[11]  
DELEAN A, 1981, MOL PHARMACOL, V21, P5
[12]  
DORJE F, 1991, J PHARMACOL EXP THER, V256, P727
[13]  
FERNANDES LB, 1992, J PHARMACOL EXP THER, V262, P119
[14]   IDENTIFICATION OF 3 MUSCARINIC RECEPTOR SUBTYPES IN RAT LUNG USING BINDING-STUDIES WITH SELECTIVE ANTAGONISTS [J].
FRYER, AD ;
ELFAKAHANY, EE .
LIFE SCIENCES, 1990, 47 (07) :611-618
[15]  
GIES JP, 1989, J PHARMACOL EXP THER, V250, P309
[16]  
GIRALDO E, 1988, J PHARMACOL EXP THER, V244, P1016
[17]   HETEROGENEITY OF GUINEA-PIG LUNG MUSCARINIC RECEPTORS REVEALED BY [H-3] 4-DAMP-BINDING [J].
HADDAD, EB ;
TRIFILIEFF, A ;
LANDRY, Y ;
GIES, JP .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 1993, 6 (02) :119-127
[18]   MUSCARINIC RECEPTOR SUBTYPES IN GUINEA-PIG AIRWAYS [J].
HADDAD, EB ;
LANDRY, Y ;
PIERREGIES, J .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (04) :L327-L333
[19]   ADAPTATION OF THE PULMONARY CIRCULATION TO EXTRA-UTERINE LIFE IN THE PIG AND ITS RELEVANCE TO THE HUMAN INFANT [J].
HAWORTH, SG ;
HISLOP, AA .
CARDIOVASCULAR RESEARCH, 1981, 15 (02) :108-119
[20]   MUSCARINIC RECEPTOR SUBTYPES [J].
HULME, EC ;
BIRDSALL, NJM ;
BUCKLEY, NJ .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1990, 30 :633-673